[go: up one dir, main page]

SG73391A1 - Steroid sulphatase inhibitors - Google Patents

Steroid sulphatase inhibitors

Info

Publication number
SG73391A1
SG73391A1 SG1996005394A SG1996005394A SG73391A1 SG 73391 A1 SG73391 A1 SG 73391A1 SG 1996005394 A SG1996005394 A SG 1996005394A SG 1996005394 A SG1996005394 A SG 1996005394A SG 73391 A1 SG73391 A1 SG 73391A1
Authority
SG
Singapore
Prior art keywords
sub
compound
steroid sulphatase
enzyme
sulphate
Prior art date
Application number
SG1996005394A
Other languages
English (en)
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Publication of SG73391A1 publication Critical patent/SG73391A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG1996005394A 1991-08-29 1992-08-28 Steroid sulphatase inhibitors SG73391A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919118478A GB9118478D0 (en) 1991-08-29 1991-08-29 Steroid sulphatase inhibitors

Publications (1)

Publication Number Publication Date
SG73391A1 true SG73391A1 (en) 2006-08-30

Family

ID=10700604

Family Applications (7)

Application Number Title Priority Date Filing Date
SG1996005394A SG73391A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003817A SG88783A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003816A SG103820A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207242A SG103374A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207238A SG115508A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207232A SG106116A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003815A SG88782A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors

Family Applications After (6)

Application Number Title Priority Date Filing Date
SG200003817A SG88783A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003816A SG103820A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207242A SG103374A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207238A SG115508A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207232A SG106116A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003815A SG88782A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors

Country Status (26)

Country Link
US (3) US5616574A (ko)
EP (6) EP0982032B1 (ko)
JP (6) JP3219408B2 (ko)
KR (4) KR100258396B1 (ko)
AT (5) ATE278704T1 (ko)
AU (2) AU689043B2 (ko)
BR (1) BR9206434A (ko)
CA (4) CA2305758A1 (ko)
CY (4) CY2253B1 (ko)
CZ (1) CZ295939B6 (ko)
DE (5) DE69231280T2 (ko)
DK (4) DK0928609T3 (ko)
ES (4) ES2148178T3 (ko)
FI (5) FI940903A (ko)
GB (1) GB9118478D0 (ko)
GE (6) GEP20022802B (ko)
GR (1) GR3034579T3 (ko)
HK (3) HK1019753A1 (ko)
HU (1) HUT66097A (ko)
LV (1) LV12618B (ko)
NO (6) NO307301B1 (ko)
RU (4) RU2182152C2 (ko)
SG (7) SG73391A1 (ko)
SK (4) SK282187B6 (ko)
UA (4) UA41875C2 (ko)
WO (1) WO1993005064A1 (ko)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011024A (en) * 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6083978A (en) * 1996-03-05 2000-07-04 Sterix Limited Compounds with a sulfamate group
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9604709D0 (en) * 1996-03-05 1996-05-01 Imperial College A compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
AU2112995A (en) * 1994-04-05 1995-10-23 Celltech Therapeutics Limited Use of estrone derivatives as steroid sulphatase inhibitors
DE4447714C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
US6506792B1 (en) 1997-03-04 2003-01-14 Sterix Limited Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using
US6921776B1 (en) 1996-02-16 2005-07-26 Sterix Limited Compound
KR20000035979A (ko) * 1996-09-12 2000-06-26 야마구찌 다까시 3-치환-d-호모-1,3,5(10)-에스트라트리엔 유도체
US6642220B1 (en) * 1996-12-05 2003-11-04 Sterix Limited Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
GB9708716D0 (en) * 1997-04-29 1997-06-18 Imperial College Chronic heart failure
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
ATE401896T1 (de) * 1998-06-10 2008-08-15 Sterix Ltd Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
WO2000053620A1 (fr) * 1999-03-10 2000-09-14 Nippon Organon K. K. Nouveaux derives d'oestradiol
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−1,3,5(10),16−テトラエン誘導体
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
AU2005225148B2 (en) * 1999-04-30 2008-04-03 Sterix Limited Use
EP1173182A2 (en) * 1999-04-30 2002-01-23 Sterix Limited Use of estrone derivatives as antitumour agents
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
WO2001044268A1 (en) * 1999-12-13 2001-06-21 Sterix Limited Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
AU2001248849A1 (en) * 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
WO2003006027A1 (en) * 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE60229009D1 (de) 2001-10-18 2008-10-30 Sterix Ltd Steroidale Verbindungen zur Hemmung von steroid Sulfotase
PT1448592E (pt) * 2001-10-18 2006-07-31 Sterix Ltd Compostos esteroides para inibicao da esteroide sulfatase
US20040254241A1 (en) * 2002-08-28 2004-12-16 Yoji Ino Aryl sulfamate derivatives
CA2501556A1 (en) * 2002-10-09 2004-04-29 Kyowa Hakko Kogyo Co., Ltd. Remedy for hormone-dependent cancer
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE10307104A1 (de) 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
SI1644350T1 (sl) * 2003-05-16 2009-12-31 Theramex Sulfamat benzotiofenski derivati kot inhibitorji steroid sulfataze
DE602004026571D1 (en) 2003-05-21 2010-05-27 Aska Pharm Co Ltd Cyclisches aminophenylsulfamatderivativ
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
WO2009037539A2 (en) 2007-09-17 2009-03-26 Preglem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women
EP2149371A1 (en) * 2008-07-28 2010-02-03 PregLem S.A. Use of steroid sulfatase inhibitors for the treatment of preterm labor
CN102316902B (zh) 2009-02-20 2014-09-24 to-BBB控股股份有限公司 基于谷胱甘肽的药物递送系统
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
CN110974840A (zh) * 2019-12-27 2020-04-10 天津市肿瘤医院 一种类固醇硫酸酯酶抑制剂及其药物用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
DD114806A1 (ko) * 1974-10-11 1975-08-20

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE114806C (ko) *
DE1593846A1 (de) * 1967-01-28 1971-02-25 Hoechst Ag Verfahren zur Herstellung von Sulfamidsaeure-arylestern
US3647738A (en) * 1970-11-03 1972-03-07 Union Carbide Corp Alpha-olefin polymer compositions
DE2418217A1 (de) * 1974-04-13 1975-11-06 Hoechst Ag Sulfamidsaeureester und verfahren zu ihrer herstellung
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
PT94305B (pt) * 1989-06-12 1997-02-28 Robins Co Inc A H Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
US6083978A (en) * 1996-03-05 2000-07-04 Sterix Limited Compounds with a sulfamate group
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
DD114806A1 (ko) * 1974-10-11 1975-08-20

Also Published As

Publication number Publication date
HU9400583D0 (en) 1994-05-30
DE69233431T2 (de) 2006-02-23
BR9206434A (pt) 1994-09-27
EP0641355B1 (en) 2000-07-19
FI940903A (fi) 1994-04-20
UA41875C2 (uk) 2001-10-15
CY2253B1 (en) 2003-07-04
NO308774B1 (no) 2000-10-30
NO307301B1 (no) 2000-03-13
SG103374A1 (en) 2004-04-29
EP0641355A1 (en) 1995-03-08
SK24694A3 (en) 1994-11-09
JP2002255993A (ja) 2002-09-11
RU2210574C2 (ru) 2003-08-20
GB9118478D0 (en) 1991-10-16
RU2182152C2 (ru) 2002-05-10
DE69233149T2 (de) 2004-06-24
NO308903B1 (no) 2000-11-13
CZ44094A3 (en) 1995-01-18
JP3581820B2 (ja) 2004-10-27
EP0928609A2 (en) 1999-07-14
CY2394B1 (en) 2004-09-10
ES2193475T3 (es) 2003-11-01
RU2001125673A (ru) 2003-06-27
RU94019334A (ru) 1996-10-20
UA70958C2 (uk) 2004-11-15
JP3219408B2 (ja) 2001-10-15
LV12618A (en) 2001-02-20
HUT66097A (en) 1994-09-28
ES2204059T3 (es) 2004-04-16
NO318009B1 (no) 2005-01-17
EP1099706B1 (en) 2004-10-06
NO995076D0 (no) 1999-10-18
KR100258396B1 (ko) 2000-08-01
GEP20022766B (en) 2002-08-26
JP2000355542A (ja) 2000-12-26
HK1020672A1 (en) 2000-05-19
ES2196483T3 (es) 2003-12-16
CY2397B1 (en) 2004-09-10
JPH07501515A (ja) 1995-02-16
SG88782A1 (en) 2002-05-21
DE69233020T2 (de) 2003-11-06
KR100322650B1 (ko) 2002-03-20
DE69231280T2 (de) 2000-11-30
ATE246706T1 (de) 2003-08-15
ATE237333T1 (de) 2003-05-15
NO995076L (no) 1994-04-29
LV12618B (en) 2001-07-20
EP0921130B1 (en) 2003-05-07
AU668882B2 (en) 1996-05-23
GEP20063773B (en) 2006-03-27
DE69233053D1 (de) 2003-06-12
EP0928609A3 (en) 2001-11-07
CY2398B1 (en) 2004-09-10
RU2207134C2 (ru) 2003-06-27
US5616574A (en) 1997-04-01
GEP20022802B (en) 2002-09-25
EP1099706A2 (en) 2001-05-16
UA70957C2 (uk) 2004-11-15
DE69233431D1 (de) 2004-11-11
DK0641355T3 (da) 2000-10-09
JP2000355598A (ja) 2000-12-26
AU2490592A (en) 1993-04-05
WO1993005064A1 (en) 1993-03-18
CA2305758A1 (en) 1993-03-18
KR100321018B1 (ko) 2002-03-20
NO20044458L (no) 1994-04-29
GEP20033094B (en) 2003-10-27
FI940903A0 (fi) 1994-02-25
NO314287B1 (no) 2003-03-03
EP0921130A3 (en) 2001-09-05
SG106116A1 (en) 2004-09-30
GEP20022803B (en) 2002-09-25
JP2003176297A (ja) 2003-06-24
AU5837396A (en) 1996-09-05
FI20002261L (fi) 2000-10-13
SK282187B6 (sk) 2001-12-03
ATE278704T1 (de) 2004-10-15
US6159960A (en) 2000-12-12
SK282189B6 (sk) 2001-12-03
JP3581802B2 (ja) 2004-10-27
NO940635L (ko) 1994-04-29
CZ295939B6 (cs) 2005-12-14
JP2000038341A (ja) 2000-02-08
UA70956C2 (uk) 2004-11-15
EP0921130A2 (en) 1999-06-09
HK1019753A1 (en) 2000-02-25
SK282186B6 (sk) 2001-12-03
US5830886A (en) 1998-11-03
EP1099706A3 (en) 2002-09-04
CA2305767A1 (en) 1993-03-18
DE69233020D1 (de) 2003-05-22
EP0982032B1 (en) 2003-08-06
ATE194843T1 (de) 2000-08-15
NO2595A (no) 1994-04-29
NO20025725L (no) 1994-04-29
NO20002595D0 (no) 2000-05-19
FI20050991L (fi) 2005-10-03
NO20025725D0 (no) 2002-11-28
ES2148178T3 (es) 2000-10-16
KR100321019B1 (ko) 2002-03-20
FI20002260L (fi) 2000-10-13
NO995075D0 (no) 1999-10-18
FI20002259L (fi) 2000-10-13
AU1007799A (en) 1999-03-04
EP0982032A2 (en) 2000-03-01
DK0982032T3 (da) 2003-11-03
SG88783A1 (en) 2002-05-21
SG115508A1 (en) 2005-10-28
DE69231280D1 (de) 2000-08-24
SK282188B6 (sk) 2001-12-03
DK0928609T3 (da) 2003-07-21
HK1025051A1 (en) 2000-11-03
DE69233149D1 (de) 2003-09-11
EP0928609B1 (en) 2003-04-16
EP0982032A3 (en) 2002-03-20
DK0921130T3 (da) 2003-07-21
CA2114630C (en) 2003-09-30
AU689043B2 (en) 1998-03-19
AU717116B2 (en) 2000-03-16
CA2114630A1 (en) 1993-03-18
CA2305749A1 (en) 1993-03-18
GR3034579T3 (en) 2001-01-31
SG103820A1 (en) 2004-05-26
JP3581821B2 (ja) 2004-10-27
DE69233053T2 (de) 2003-11-20
NO995075L (no) 1994-04-29
EP1522543A1 (en) 2005-04-13
GEP20022637B (en) 2002-02-25
ATE239753T1 (de) 2003-05-15
NO940635D0 (no) 1994-02-24

Similar Documents

Publication Publication Date Title
AU689043B2 (en) Steroid sulphatase inhibitors